Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong
· Delayed Price · Currency is HKD 5.46
-0.02 (-0.36%)
Apr 29, 2026, 4:08 PM HKT
Sino Biopharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12,181 | 9,570 | 9,452 | 12,066 | 10,569 | Upgrade
|
| Short-Term Investments | - | 220.64 | 1,553 | - | 569.5 | Upgrade
|
| Trading Asset Securities | 10,366 | 5,028 | 3,113 | 4,855 | 4,656 | Upgrade
|
| Cash & Short-Term Investments | 22,547 | 14,818 | 14,118 | 16,922 | 15,794 | Upgrade
|
| Cash Growth | 52.16% | 4.96% | -16.57% | 7.14% | -3.88% | Upgrade
|
| Accounts Receivable | 6,264 | 5,013 | 4,596 | 4,643 | 4,285 | Upgrade
|
| Other Receivables | 376.4 | 1,787 | 1,602 | 1,575 | 1,164 | Upgrade
|
| Receivables | 6,640 | 6,800 | 6,199 | 6,219 | 5,537 | Upgrade
|
| Inventory | 2,257 | 2,373 | 1,993 | 2,329 | 1,938 | Upgrade
|
| Prepaid Expenses | 3,022 | 694.17 | 582.57 | 465.69 | 234.13 | Upgrade
|
| Other Current Assets | - | - | 912.71 | - | - | Upgrade
|
| Total Current Assets | 34,465 | 24,685 | 23,806 | 25,935 | 23,503 | Upgrade
|
| Property, Plant & Equipment | 10,233 | 10,288 | 9,912 | 9,251 | 8,516 | Upgrade
|
| Long-Term Investments | 23,465 | 26,337 | 25,181 | 25,230 | 25,169 | Upgrade
|
| Goodwill | 3,496 | 915.69 | 680.45 | 662.61 | 647.93 | Upgrade
|
| Other Intangible Assets | 3,556 | 271.89 | 248.49 | 278.35 | 291.56 | Upgrade
|
| Long-Term Deferred Tax Assets | 506.59 | 516.29 | 567.01 | 505.15 | 334.87 | Upgrade
|
| Long-Term Deferred Charges | - | 1,873 | 1,980 | 973.49 | 772.46 | Upgrade
|
| Other Long-Term Assets | 287.51 | 520.8 | 1,230 | 1,229 | 1,308 | Upgrade
|
| Total Assets | 76,010 | 65,408 | 63,605 | 64,064 | 60,543 | Upgrade
|
| Accounts Payable | 1,497 | 1,497 | 1,335 | 1,884 | 1,795 | Upgrade
|
| Accrued Expenses | - | 7,651 | 6,716 | 6,299 | 5,146 | Upgrade
|
| Short-Term Debt | - | - | 136.13 | 136.13 | 136.13 | Upgrade
|
| Current Portion of Long-Term Debt | 8,395 | 7,602 | 11,136 | 9,663 | 6,521 | Upgrade
|
| Current Portion of Leases | 23.29 | 28.33 | 71.49 | 60.43 | 64.47 | Upgrade
|
| Current Income Taxes Payable | 696.15 | 318.2 | 271.87 | 107.46 | 101.17 | Upgrade
|
| Current Unearned Revenue | - | 253.24 | 282.6 | 310.79 | 238.2 | Upgrade
|
| Other Current Liabilities | 14,587 | 2,206 | 2,658 | 1,690 | 1,344 | Upgrade
|
| Total Current Liabilities | 25,200 | 19,556 | 22,607 | 20,151 | 15,345 | Upgrade
|
| Long-Term Debt | 7,584 | 1,997 | 1,074 | 3,934 | 5,213 | Upgrade
|
| Long-Term Leases | 67.31 | 83.39 | 298.39 | 324.26 | 319.95 | Upgrade
|
| Long-Term Unearned Revenue | 621.88 | 557.92 | 548.27 | 749.07 | 674.45 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 286.4 | 237.55 | 781.54 | 831.79 | 881.59 | Upgrade
|
| Other Long-Term Liabilities | 164.76 | 201.9 | 125.46 | 131.08 | 380.78 | Upgrade
|
| Total Liabilities | 33,924 | 22,634 | 25,435 | 26,121 | 22,814 | Upgrade
|
| Common Stock | 413.67 | 414.38 | 414.62 | 414.9 | 415.44 | Upgrade
|
| Additional Paid-In Capital | - | 12,421 | 12,443 | 12,484 | 12,578 | Upgrade
|
| Retained Earnings | - | 25,281 | 23,649 | 28,358 | 27,215 | Upgrade
|
| Treasury Stock | -2,951 | -2,975 | -1,770 | -1,432 | -689.35 | Upgrade
|
| Comprehensive Income & Other | 33,209 | -3,180 | -4,262 | -10,078 | -9,228 | Upgrade
|
| Total Common Equity | 30,671 | 31,961 | 30,474 | 29,747 | 30,291 | Upgrade
|
| Minority Interest | 11,415 | 10,813 | 7,695 | 8,197 | 7,438 | Upgrade
|
| Shareholders' Equity | 42,086 | 42,774 | 38,170 | 37,944 | 37,729 | Upgrade
|
| Total Liabilities & Equity | 76,010 | 65,408 | 63,605 | 64,064 | 60,543 | Upgrade
|
| Total Debt | 16,070 | 9,711 | 12,716 | 14,118 | 12,254 | Upgrade
|
| Net Cash (Debt) | 6,477 | 5,107 | 1,402 | 2,804 | 3,540 | Upgrade
|
| Net Cash Growth | 26.81% | 264.34% | -50.00% | -20.81% | 59.33% | Upgrade
|
| Net Cash Per Share | 0.36 | 0.28 | 0.08 | 0.15 | 0.18 | Upgrade
|
| Filing Date Shares Outstanding | 17,892 | 17,924 | 18,347 | 18,468 | 18,699 | Upgrade
|
| Total Common Shares Outstanding | 17,892 | 17,924 | 18,347 | 18,468 | 18,699 | Upgrade
|
| Working Capital | 9,266 | 5,129 | 1,199 | 5,784 | 8,158 | Upgrade
|
| Book Value Per Share | 1.71 | 1.78 | 1.66 | 1.61 | 1.62 | Upgrade
|
| Tangible Book Value | 23,619 | 30,773 | 29,546 | 28,806 | 29,352 | Upgrade
|
| Tangible Book Value Per Share | 1.32 | 1.72 | 1.61 | 1.56 | 1.57 | Upgrade
|
| Buildings | - | 5,016 | 4,248 | 3,871 | 3,571 | Upgrade
|
| Machinery | - | 8,433 | 7,628 | 6,692 | 6,132 | Upgrade
|
| Construction In Progress | - | 1,701 | 1,686 | 1,804 | 1,426 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.